SAVIMS

Other scientific evidence

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Updated COVID-19 Adverse Events Following Immunisation

Reference: CEPI. (2022, October). COVID-19 AESI including status of associated Brighton case definitions. Retrieved from [insert URL here] Summary: The document presents an updated list of Adverse Events Following Immunisation (AESI) related to COVID-19, alongside their Brighton case definitions. It categorises various conditions such as acute respiratory distress syndrome, myocarditis, and thrombosis, indicating their publication […]

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19 Associated Events of Special Interest: A Comprehensive Overview

Reference: CEPI. (2021). COVID-19 associated events of special interest including status of associated Brighton case definitions. Retrieved from https://docs.google.com/spreadsheets/d/1QgF35nYcsaFN3DZTOtV_lP0TYqQzsDMUQBAd5M9brrM/edit#gid=1666959512 Summary: This document provides an overview of COVID-19 associated events of special interest (AESI) alongside their Brighton case definitions as of October 2021. It categorises AESIs into three groups: those seen with COVID-19 disease, those with

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Concerns Over COVID-19 Vaccination for Children Aged 5-11

Reference: Kennedy, R. F., & Nass, M. (2021). Concerns over COVID-19 vaccination for children aged 5-11. Retrieved from Children’s Health Defense. Summary: In a letter to the FDA and VRBPAC members, Children’s Health Defense (CHD) expressed strong opposition to the potential Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine for children aged 5-11. The

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Majority of COVID-19 Deaths in Sweden and UK Among Fully Vaccinated

Reference: Wolfe, R. (2021, October 21). Fully vaccinated were the majority of COVID deaths in Sweden, UK in September. LifeSite. https://www.lifesitenews.com/news/fully-vaccinated-people-now-the-majority-of-covid-deaths-in-uk-sweden/ Summary: Recent data from Sweden and the UK reveals that “fully vaccinated” individuals comprised the majority of COVID-19 deaths in September 2021. In Sweden, 70% of COVID fatalities between September 1-24 were among fully

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Summary of Public Health Scotland’s COVID-19 Statistical Report (Public Health Scotland – 2021)

Reference: Public Health Scotland. (2021). COVID-19 statistical report: As at 18 October 2021. Retrieved from https://www.publichealthscotland.scot/ Summary: The Public Health Scotland COVID-19 Statistical Report, published on 20 October 2021, provides a comprehensive overview of COVID-19 incidence and related data in Scotland. As of 17 October 2021, there were 609,959 confirmed cases, with a notable decrease

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Annual Renewal Assessment of Comirnaty Marketing Authorisation

Reference: European Medicines Agency (2021). Assessment report on the annual renewal of the conditional marketing authorisation for Comirnaty (COVID-19 mRNA vaccine). EMA/596333/2021. Summary: The European Medicines Agency (EMA) conducted an assessment for the annual renewal of the conditional marketing authorisation (CMA) for Comirnaty, a COVID-19 mRNA vaccine developed by BioNTech. Originally granted on 21 December

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Annual Renewal of Conditional Marketing Authorisation for Comirnaty

Reference: European Medicines Agency. (2021). Assessment report on the annual renewal of the conditional marketing authorisation. EMA/596333/2021. Summary: The European Medicines Agency (EMA) assessed the annual renewal of the conditional marketing authorisation for Comirnaty, a COVID-19 mRNA vaccine developed by BioNTech. Initially granted on 21 December 2020, the renewal process involved reviewing specific obligations (SOBs)

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Overview of the I-MASK+ Protocol for COVID-19 Treatment

Reference: FLCCC Alliance. (2021). I-MASK+ protocol: Prevention and early outpatient treatment protocol for COVID-19 (Version 18). Retrieved from https://www.flccc.net/covid-19-protocols Summary: The I-MASK+ protocol, developed by the Front Line COVID-19 Critical Care Alliance (FLCCC), is designed for the prevention and early outpatient treatment of COVID-19, particularly against the Delta variant. It emphasises the use of ivermectin

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Vaccine Adverse Reactions in the EU: Alarming Statistics

Reference: Shilhavy, B. (2021). 20,595 dead, 1.9 million injured (50% serious) reported in European Union’s database of adverse drug reactions for COVID-19 shots. Vaccine Impact. Retrieved from https://vaccineimpact.com/2021/20595-dead-1-9-million-injured-50-serious-reported-in-european-unions-database-of-adverse-drug-reactions-for Summary: The EudraVigilance database, which records suspected drug reactions in 27 EU countries, reported 20,595 fatalities and nearly 1.96 million injuries linked to COVID-19 vaccinations by July

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Estimating COVID Vaccine Deaths in America

Reference: Kirsch, S., Rose, J., & Crawford, M. (2021). Estimating the number of COVID vaccine deaths in America. Retrieved from [insert URL] Summary: This article evaluates data from the Vaccine Adverse Event Reporting System (VAERS) to estimate the number of excess deaths attributed to COVID-19 vaccinations in the United States. The authors argue that over

Scroll to Top